In a recent MetS case control study, Phillips et al. examined the relationship between lymphotoxin-α (LTA), IL-6, and TNF-α genetic variants with MetS risk in the LIPGENE-SU.VI.MAX cohort [92]. Here, IL6 is linked to metabolic syndrome.